Although the results should be evaluated in light of these limitations and strengths, this translational study seems to indicate that ER(+) and ER(−) HER2-positive BC should be considered as two distinctive diseases able to induce different host interactions, as mirrored by the circulatory 1H NMR metabolomic profiles. The gene discussed is ERBB2; the disease is breast cancer.